PG Biotech

PG Biotech (Suzhou) Co., Ltd. is a specialized molecular diagnostics company that develops and manufactures advanced PCR-based genomic assays. Based in Suzhou, China, the company focuses on providing high-quality diagnostic solutions for infectious diseases, with a prominent portfolio including tests for Human Papillomavirus (HPV), Hepatitis B (HBV), and Hepatitis C (HCV). In 2016, the company was acquired by Luminex Corporation for approximately $50 million to serve as a strategic hub for Luminex's expansion into the Chinese clinical market. Following the subsequent acquisition of Luminex by DiaSorin in 2021, PG Biotech now operates as a key component of DiaSorin’s molecular diagnostics division. The company’s products are widely used in clinical laboratories and hospitals for disease screening and monitoring.